US20080200449A1 - Treprostinil administration using a metered dose inhaler - Google Patents

Treprostinil administration using a metered dose inhaler Download PDF

Info

Publication number
US20080200449A1
US20080200449A1 US11/748,205 US74820507A US2008200449A1 US 20080200449 A1 US20080200449 A1 US 20080200449A1 US 74820507 A US74820507 A US 74820507A US 2008200449 A1 US2008200449 A1 US 2008200449A1
Authority
US
United States
Prior art keywords
μg
treprostinil
method
metered dose
ml
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/748,205
Inventor
Horst Olschewski
Robert Roscigno
Lewis J. Rubin
Thomas Schmehl
Werner Seeger
Carl Sterritt
Robert Voswinckel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LUNG RX Inc A WHOLLY OWNED SUBSIDIARY OF UNITED THERAPEUTICS Corp
United Therapeutics Corp
Original Assignee
United Therapeutics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US80001606P priority Critical
Application filed by United Therapeutics Corp filed Critical United Therapeutics Corp
Priority to US11/748,205 priority patent/US20080200449A1/en
Assigned to TRANSMIT GESELLSCHAFT FUR TECHNOLOGIETRANSFER MBH reassignment TRANSMIT GESELLSCHAFT FUR TECHNOLOGIETRANSFER MBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SCHMEHL, THOMAS, VOSWINCKEL, ROBERT, SEEGER, WERNER, OLSCHEWSKI, HORST
Assigned to LUNG RX, INC., A WHOLLY OWNED SUBSIDIARY OF UNITED THERAPEUTICS CORPORATION reassignment LUNG RX, INC., A WHOLLY OWNED SUBSIDIARY OF UNITED THERAPEUTICS CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: TRANSMIT GESELLSCHAFT FUR TECHNOLOGIETRANSFER MBH
Assigned to UNITED THERAPEUTICS CORPORATION reassignment UNITED THERAPEUTICS CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: STERRITT, CARL, ROSCIGNO, ROBERT, RUBIN, LEWIS J.
Assigned to LUNG RX, INC., A WHOLLY OWNED SUBSIDIARY OF UNITED THERAPEUTICS CORPORATION reassignment LUNG RX, INC., A WHOLLY OWNED SUBSIDIARY OF UNITED THERAPEUTICS CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: UNITED THERAPEUTICS CORPORATION
Publication of US20080200449A1 publication Critical patent/US20080200449A1/en
Assigned to UNITED THERAPEUTICS CORPORATION reassignment UNITED THERAPEUTICS CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LUNGRX, A WHOLLY OWNED SUBSIDIARY OF UNITED THERAPEUTICS CORPORATION
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38544006&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20080200449(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application status is Abandoned legal-status Critical

Links